ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness
Clinical trial NCT07084558 · RECRUITING
Trial details
- NCT number
- NCT07084558
- Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-13
- Primary completion
- 2028-06-30
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.